• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰肌醇-3激酶-Akt通路控制埃博拉病毒的细胞内侵入。

Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus.

作者信息

Saeed Mohammad F, Kolokoltsov Andrey A, Freiberg Alexander N, Holbrook Michael R, Davey Robert A

机构信息

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.

出版信息

PLoS Pathog. 2008 Aug 29;4(8):e1000141. doi: 10.1371/journal.ppat.1000141.

DOI:10.1371/journal.ppat.1000141
PMID:18769720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2516934/
Abstract

The phosphoinositide-3 kinase (PI3K) pathway regulates diverse cellular activities related to cell growth, migration, survival, and vesicular trafficking. It is known that Ebola virus requires endocytosis to establish an infection. However, the cellular signals that mediate this uptake were unknown for Ebola virus as well as many other viruses. Here, the involvement of PI3K in Ebola virus entry was studied. A novel and critical role of the PI3K signaling pathway was demonstrated in cell entry of Zaire Ebola virus (ZEBOV). Inhibitors of PI3K and Akt significantly reduced infection by ZEBOV at an early step during the replication cycle. Furthermore, phosphorylation of Akt-1 was induced shortly after exposure of cells to radiation-inactivated ZEBOV, indicating that the virus actively induces the PI3K pathway and that replication was not required for this induction. Subsequent use of pseudotyped Ebola virus and/or Ebola virus-like particles, in a novel virus entry assay, provided evidence that activity of PI3K/Akt is required at the virus entry step. Class 1A PI3Ks appear to play a predominant role in regulating ZEBOV entry, and Rac1 is a key downstream effector in this regulatory cascade. Confocal imaging of fluorescently labeled ZEBOV indicated that inhibition of PI3K, Akt, or Rac1 disrupted normal uptake of virus particles into cells and resulted in aberrant accumulation of virus into a cytosolic compartment that was non-permissive for membrane fusion. We conclude that PI3K-mediated signaling plays an important role in regulating vesicular trafficking of ZEBOV necessary for cell entry. Disruption of this signaling leads to inappropriate trafficking within the cell and a block in steps leading to membrane fusion. These findings extend our current understanding of Ebola virus entry mechanism and may help in devising useful new strategies for treatment of Ebola virus infection.

摘要

磷酸肌醇-3激酶(PI3K)信号通路调控着与细胞生长、迁移、存活及囊泡运输相关的多种细胞活动。已知埃博拉病毒需要通过内吞作用来建立感染。然而,介导这种摄取的细胞信号对于埃博拉病毒以及许多其他病毒来说都是未知的。在此,研究了PI3K在埃博拉病毒进入细胞过程中的作用。结果表明PI3K信号通路在扎伊尔埃博拉病毒(ZEBOV)进入细胞过程中发挥着新的关键作用。PI3K和Akt的抑制剂在复制周期的早期阶段显著降低了ZEBOV的感染。此外,细胞暴露于经辐射灭活的ZEBOV后不久,Akt-1就发生了磷酸化,这表明病毒能主动诱导PI3K信号通路,且这种诱导不需要病毒复制。随后,在一种新型病毒进入细胞检测方法中使用假型埃博拉病毒和/或埃博拉病毒样颗粒,提供了证据表明在病毒进入细胞步骤中需要PI3K/Akt的活性。1A类PI3K似乎在调节ZEBOV进入细胞过程中起主要作用,而Rac1是这一调节级联反应中的关键下游效应分子。对荧光标记的ZEBOV进行共聚焦成像显示,抑制PI3K、Akt或Rac1会破坏病毒颗粒正常进入细胞的过程,并导致病毒异常积聚在一个不允许膜融合的胞质区室中。我们得出结论,PI3K介导的信号传导在调节ZEBOV进入细胞所需的囊泡运输中起重要作用。这种信号传导的破坏会导致细胞内运输异常,并阻断导致膜融合的步骤。这些发现扩展了我们目前对埃博拉病毒进入细胞机制的理解,并可能有助于设计出治疗埃博拉病毒感染的有用新策略。

相似文献

1
Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus.磷脂酰肌醇-3激酶-Akt通路控制埃博拉病毒的细胞内侵入。
PLoS Pathog. 2008 Aug 29;4(8):e1000141. doi: 10.1371/journal.ppat.1000141.
2
Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes.埃博拉病毒的细胞进入涉及通过类似巨胞饮的机制摄取,随后通过早期和晚期内体运输。
PLoS Pathog. 2010 Sep 16;6(9):e1001110. doi: 10.1371/journal.ppat.1001110.
3
Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.埃博拉病毒触发受体酪氨酸激酶依赖性信号转导,以促进病毒颗粒向有利于进入的细胞内隔室的输送。
PLoS Pathog. 2021 Jan 29;17(1):e1009275. doi: 10.1371/journal.ppat.1009275. eCollection 2021 Jan.
4
Cathepsin B & L are not required for ebola virus replication.组织蛋白酶 B 和 L 对于埃博拉病毒的复制不是必需的。
PLoS Negl Trop Dis. 2012;6(12):e1923. doi: 10.1371/journal.pntd.0001923. Epub 2012 Dec 6.
5
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.埃博拉病毒通过病毒糖蛋白依赖的巨胞饮作用内化进入宿主细胞。
PLoS Pathog. 2010 Sep 23;6(9):e1001121. doi: 10.1371/journal.ppat.1001121.
6
Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein.酪氨酸激酶受体 Axl 增强扎伊尔埃博拉病毒的进入,而无需与病毒糖蛋白直接相互作用。
Virology. 2011 Jul 5;415(2):83-94. doi: 10.1016/j.virol.2011.04.002. Epub 2011 May 6.
7
Participation of the phosphatidylinositol 3-kinase/Akt pathway in Junín virus replication in vitro.磷脂酰肌醇3-激酶/Akt信号通路参与胡宁病毒的体外复制
Virus Res. 2009 Oct;145(1):166-70. doi: 10.1016/j.virusres.2009.07.004. Epub 2009 Jul 10.
8
Inhibition of the PI3K/Akt pathway by Ly294002 does not prevent establishment of persistent Junín virus infection in Vero cells.Ly294002对PI3K/Akt途径的抑制作用并不能阻止朱宁病毒在Vero细胞中建立持续性感染。
Arch Virol. 2015 Feb;160(2):469-75. doi: 10.1007/s00705-014-2298-6. Epub 2014 Dec 7.
9
The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.酪氨酸蛋白激酶受体 Tyro3(Axl)增强扎伊尔埃博拉病毒的巨胞饮作用。
J Virol. 2011 Jan;85(1):334-47. doi: 10.1128/JVI.01278-09. Epub 2010 Nov 3.
10
The PI3K/Akt pathway contributes to arenavirus budding.PI3K/Akt 通路有助于沙粒病毒出芽。
J Virol. 2012 Apr;86(8):4578-85. doi: 10.1128/JVI.06604-11. Epub 2012 Feb 15.

引用本文的文献

1
Inositol metabolism as a broad-spectrum antiviral target.肌醇代谢作为一种广谱抗病毒靶点。
Front Microbiol. 2025 Aug 26;16:1620775. doi: 10.3389/fmicb.2025.1620775. eCollection 2025.
2
Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus.从针对呼吸道合胞病毒的传播模式探索治疗靶点。
FASEB J. 2025 Jul 31;39(14):e70858. doi: 10.1096/fj.202500509RR.
3
Screening of neurotransmitter receptor modulators reveals novel inhibitors of influenza virus replication.神经递质受体调节剂的筛选揭示了流感病毒复制的新型抑制剂。

本文引用的文献

1
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.一种具有抗肿瘤和抗血管生成活性的血管靶向性泛磷酸肌醇3激酶抑制剂前药,SF1126。
Cancer Res. 2008 Jan 1;68(1):206-15. doi: 10.1158/0008-5472.CAN-07-0669.
2
Filoviruses: Interactions with the host cell.丝状病毒:与宿主细胞的相互作用
Cell Mol Life Sci. 2008 Mar;65(5):756-76. doi: 10.1007/s00018-007-7406-2.
3
PI3K/PTEN signaling in tumorigenesis and angiogenesis.PI3K/PTEN信号传导在肿瘤发生和血管生成中的作用
Front Cell Infect Microbiol. 2025 Apr 29;15:1562650. doi: 10.3389/fcimb.2025.1562650. eCollection 2025.
4
Cilnidipine exerts antiviral effects in vitro and in vivo by inhibiting the internalization and fusion of influenza A virus.西尼地平通过抑制甲型流感病毒的内化和融合在体外和体内发挥抗病毒作用。
BMC Med. 2025 Apr 7;23(1):200. doi: 10.1186/s12916-025-04022-0.
5
Viral interactions with host factors (TIM-1, TAM -receptors, Glut-1) are related to the disruption of glucose and ascorbate transport and homeostasis, causing the haemorrhagic manifestations of viral haemorrhagic fevers.病毒与宿主因子(TIM-1、TAM 受体、Glut-1)的相互作用与葡萄糖和抗坏血酸转运及体内平衡的破坏有关,从而导致病毒性出血热的出血表现。
F1000Res. 2024 Dec 9;12:518. doi: 10.12688/f1000research.134121.2. eCollection 2023.
6
Multiple cell types support productive infection and dynamic translocation of infectious Ebola virus to the surface of human skin.多种细胞类型支持埃博拉病毒的有效感染以及感染性埃博拉病毒向人体皮肤表面的动态转运。
Sci Adv. 2025 Jan 3;11(1):eadr6140. doi: 10.1126/sciadv.adr6140. Epub 2025 Jan 1.
7
Proteomics Analysis of Duck Lung Tissues in Response to Highly Pathogenic Avian Influenza Virus.高致病性禽流感病毒感染后鸭肺组织的蛋白质组学分析
Microorganisms. 2024 Jun 25;12(7):1288. doi: 10.3390/microorganisms12071288.
8
Identification and Potential Roles of Human MicroRNAs in Ebola Virus Infection and Disease Pathogenesis.人类微小RNA在埃博拉病毒感染及疾病发病机制中的鉴定及潜在作用
Genes (Basel). 2024 Mar 25;15(4):403. doi: 10.3390/genes15040403.
9
Reduced insulin/IGF-1 signalling upregulates two anti-viral immune pathways, decreases viral load and increases survival under viral infection in C. elegans.胰岛素/IGF-1 信号通路的降低会上调两种抗病毒免疫途径,减少线虫体内的病毒载量,并在病毒感染下提高存活率。
Geroscience. 2024 Dec;46(6):5767-5780. doi: 10.1007/s11357-024-01147-7. Epub 2024 Apr 8.
10
Transcriptome analysis of salivary glands of rabies-virus-infected mice.狂犬病病毒感染小鼠唾液腺的转录组分析
Front Microbiol. 2024 Feb 6;15:1354936. doi: 10.3389/fmicb.2024.1354936. eCollection 2024.
Biochim Biophys Acta. 2008 Jan;1784(1):150-8. doi: 10.1016/j.bbapap.2007.09.008. Epub 2007 Sep 29.
4
Rotavirus replication in intestinal cells differentially regulates integrin expression by a phosphatidylinositol 3-kinase-dependent pathway, resulting in increased cell adhesion and virus yield.轮状病毒在肠道细胞中的复制通过磷脂酰肌醇3激酶依赖性途径差异性地调节整合素表达,从而导致细胞黏附增加和病毒产量提高。
J Virol. 2008 Jan;82(1):148-60. doi: 10.1128/JVI.01980-07. Epub 2007 Oct 17.
5
Inhibition of PI3K synergistically enhances the apoptotic effect of STI-571 on p210(bcr-abl)-transformed cells in a Rac1-dependent manner.
Leuk Res. 2008 Mar;32(3):517-9. doi: 10.1016/j.leukres.2007.07.018. Epub 2007 Sep 6.
6
Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2.脊髓灰质炎病毒进入人脑微血管细胞需要受体诱导的SHP-2激活。
EMBO J. 2007 Sep 5;26(17):4016-28. doi: 10.1038/sj.emboj.7601831. Epub 2007 Aug 23.
7
Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 pathway in microglia.瘦素诱导的白细胞介素-6生成是由小胶质细胞中的瘦素受体、胰岛素受体底物-1、磷脂酰肌醇3激酶、蛋白激酶B、核因子κB和p300信号通路介导的。
J Immunol. 2007 Jul 15;179(2):1292-302. doi: 10.4049/jimmunol.179.2.1292.
8
Actin in membrane trafficking.肌动蛋白在膜运输中的作用。
Curr Opin Cell Biol. 2007 Aug;19(4):453-8. doi: 10.1016/j.ceb.2007.04.017. Epub 2007 Jul 5.
9
AKT/PKB signaling: navigating downstream.AKT/蛋白激酶B信号传导:下游通路解析
Cell. 2007 Jun 29;129(7):1261-74. doi: 10.1016/j.cell.2007.06.009.
10
Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-alpha production in response to titanium particles in vitro.抑制PI3K-Akt信号通路可降低体外对钛颗粒产生的肿瘤坏死因子-α水平。
J Bone Joint Surg Am. 2007 May;89(5):1019-27. doi: 10.2106/JBJS.F.00615.